Cargando…
A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice
Specific anti-CD3 treatment is deemed to be a promising therapy for allograft rejection and type 1 diabetes (T1D). Fc receptor (FcR) reduced-binding antibodies, by avoiding adverse effects of Fc and FcR interaction, have good therapeutic potential. We generated a trivalent anti-mouse-CD3 Collabody,...
Autores principales: | Huang, Chuan-Chuan, Sung, Hsiang-Hsuan, Li, Hsiu-Chuan, Miaw, Shi-Chuen, Kung, John T., Chou, Min-Yuan, Wu-Hsieh, Betty A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435756/ https://www.ncbi.nlm.nih.gov/pubmed/37600814 http://dx.doi.org/10.3389/fimmu.2023.1201853 |
Ejemplares similares
-
Optimal Aggregation of FcεRI with a Structurally
Defined Trivalent Ligand Overrides Negative Regulation Driven by Phosphatases
por: Mahajan, Avanika, et al.
Publicado: (2014) -
Quality Assessment of Deep-Frying Palm Oil by Impedimetric Sensing with a Simple and Economic Electrochemical Cell
por: Kung, Yi, et al.
Publicado: (2021) -
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway
por: Fife, Brian T., et al.
Publicado: (2006) -
NOD Dendritic Cells Stimulated with Lactobacilli Preferentially Produce IL-10 versus IL-12 and Decrease Diabetes Incidence
por: Manirarora, Jean N., et al.
Publicado: (2011) -
Nothing lasts forever - a critical look at sustained remission
por: Aletaha, Daniel
Publicado: (2012)